Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.90% | 58.57 | 0.0% | $919.92m | |
| AMGN | Amgen, Inc. | 1.22% | 258.24 | 1.3% | $759.50m | |
| GILD | Gilead Sciences, Inc. | 0.38% | 76.35 | 1.0% | $735.36m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.18% | 622.45 | 2.5% | $672.88m | |
| NVAX | Novavax, Inc. | 2.43% | 81.64 | 102.0% | $616.96m | |
| BIIB | Biogen, Inc. | 0.13% | 265.12 | 1.6% | $544.40m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.68% | 291.10 | 1.9% | $526.40m | |
| ILMN | Illumina, Inc. | 1.24% | 373.10 | 3.5% | $309.63m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.08% | 112.30 | 2.0% | $225.16m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.75% | 126.78 | 4.3% | $216.16m | |
| SGEN | Seattle Genetics, Inc. | 0.90% | 169.03 | 6.1% | $202.76m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.15% | 6.85 | 1.8% | $187.20m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.77% | 162.75 | 13.9% | $164.07m | |
| INCY | Incyte Corp. | 3.72% | 106.47 | 2.5% | $163.74m | |
| IMMU | Immunomedics, Inc. | 1.71% | 37.54 | 13.3% | $157.98m |
Company Profile
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.